Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Harvard Business School
AstraZeneca
McKinsey
Boehringer Ingelheim

Last Updated: January 26, 2022

Volunteer for clinical trials for atorvastatin calcium at ClinicalTrialExchange

DrugPatentWatch Database Preview

Atorvastatin calcium - Generic Drug Details

➤ Subscribe for complete access

« Back to Dashboard

What are the generic sources for atorvastatin calcium and what is the scope of freedom to operate?

Atorvastatin calcium is the generic ingredient in four branded drugs marketed by Accord Hlthcare, Alkem Labs Ltd, Apotex Inc, August, Dr Reddys Labs Ltd, Graviti Pharms, Invagen Pharms, Lannett Co Inc, Lupin Ltd, Micro Labs Ltd India, MSN, Mylan Pharms Inc, Perrigo R And D, Sandoz Inc, Sciegen Pharms Inc, Sun Pharm Inds Ltd, Teva Pharms, Teva Pharms Usa, Umedica Labs Pvt Ltd, Zydus Pharms, Upjohn, Scov3, and Organon, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-two drug master file entries for atorvastatin calcium. Fifty-four suppliers are listed for this compound.

Drug Sales Revenue Trends for atorvastatin calcium

See drug sales revenues for atorvastatin calcium

Recent Clinical Trials for atorvastatin calcium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GCP-unit at Odense University HospitalN/A
Lars Peter RiberN/A
Odense Patient Data Explorative NetworkN/A

See all atorvastatin calcium clinical trials

Pharmacology for atorvastatin calcium
Medical Subject Heading (MeSH) Categories for atorvastatin calcium
Anatomical Therapeutic Chemical (ATC) Classes for atorvastatin calcium
Paragraph IV (Patent) Challenges for ATORVASTATIN CALCIUM
Tradename Dosage Ingredient NDA Submissiondate
LIPITOR TABLET;ORAL atorvastatin calcium 020702

US Patents and Regulatory Information for atorvastatin calcium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Micro Labs Ltd India ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 205945-003 Nov 7, 2019 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Sciegen Pharms Inc ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 205519-003 May 19, 2016 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Dr Reddys Labs Ltd ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 214659-001 Jul 14, 2021 DISCN No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Lannett Co Inc ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 091624-002 Apr 5, 2013 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Lupin Ltd ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 204991-003 Mar 6, 2019 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Micro Labs Ltd India ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 205945-001 Nov 7, 2019 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Alkem Labs Ltd ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 209288-004 Dec 21, 2018 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for atorvastatin calcium

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Johnson and Johnson
Medtronic
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.